Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | CA9 | Q16790 | 3/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 3/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KDR | P35968 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gentisic Acid SCHEMBL30233582 | 1.00 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL3690 | 1.00 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL2053863 | 1.00 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL455606 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL344389 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL450480 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL8922036 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL3981503 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL10975219 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Gentisic Acid SCHEMBL10980548 | 0.98 | CA1 (0.95) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6106 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094685-A | Use of dihydroberberine or derivatives thereof for regulating or improving emotion | — | 2026-05-26 | — | — | CN | claimed |
| CN-122071832-A | Polyethylene non-woven fabric and preparation method, preparation device and application thereof | 中国石油化工股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| CN-122060696-A | Nonspecific peroxidase HecUPO, coding gene thereof, recombinant microorganism, steroid 16 alpha-hydroxylation method and application | 湖北大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122039420-A | Antibacterial stainless steel fiber and preparation method thereof | 山东闻道科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122036704-A | Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof | 江苏豪森药业集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122012422-A | Cytochrome P450 enzyme mutant and application thereof in hydroxylation | 沈阳药科大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122017061-A | Method for detecting polysorbate 80 based on combined technology of MALDI-MS and UHPLC-Q-TOF/MS | 江苏省药品监督检验研究院 | 2026-05-12 | — | — | CN | claimed |
| US-12616687-B2 | Treatment of viral infection, disease or disorder using a selective sir agonist | PRILENIA NEUROTHERAPEUTICS LTD. (IL) | 2026-05-05 | — | — | US | claimed |
| US-20260103439-A1 | Modified Tetracyclines for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes | UNIV TEXAS TECH SYSTEM (US) | 2026-04-16 | — | — | US | claimed |
| US-20260060967-A1 | USE OF PRIDOPIDINE FOR TREATING HUNTINGTON DISEASE | PRILENIA NEUROTHERAPEUTICS LTD. (IL) | 2026-03-05 | — | — | US | claimed |
| WO-2022053801-A1 | CALIBRATION AND TUNING METHOD FOR MASS SPECTROMETER | NPL MANAGEMENT LIMITED (GB) | 2022-03-17 | — | — | WO | claimed |
| EP-3503877-B1 | BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXIN | AKINA INC (US) | 2022-03-16 | — | — | EP | claimed |
| CN-110133118-B | Method for determining related substances of mesalazine enteric sustained-release tablets | 重庆健能医药开发有限公司 | 2022-03-11 | — | — | CN | claimed |
| US-11266654-B2 | Apilimod compositions and methods for using same | AI Therapeutics, Inc. (US) | 2022-03-08 | — | — | US | claimed |
| CN-114144454-A | Improved operating time to open-run time ratio by adding phenolic catalysts to polyaspartic flooring formulations | 科思创有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-109799292-B | Mesalazine enema related substance determination method | 重庆健能医药开发有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-112546883-B | Polyelectrolyte, preparation and application thereof, polyelectrolyte ultrafiltration membrane, preparation and application thereof | 吉林大学 | 2022-02-15 | — | — | CN | claimed |
| US-20220031739-A1 | ANTI-VIRAL COMPOSITIONS AND METHODS OF USE THEREOF | EYE THERAPIES LLC | 2022-02-03 | — | — | US | claimed |
| EP-3694843-B1 | NEW SALT AND SOLID STATE FORMS OF ESCITALOPRAM | HASLETON MARK (IL) | 2022-01-26 | — | — | EP | claimed |
| CN-113956202-A | Method for realizing asymmetric alpha-hydroxylation of pyrazolone compounds by phase transfer catalytic photosensitive molecular oxygen | 新乡医学院 | 2022-01-21 | — | — | CN | claimed |